Rare diseases
Investigational molecules
Locations
Study on Long-Term Safety and Effects of Iptacopan for Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
CzechiaEfficacy and Safety of REGN7508, REGN9933, and Rivaroxaban in Adults with Peripheral Artery Disease after Recent Lower‑Extremity Revascularization
CzechiaPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
CzechiaStudy of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications
CzechiaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
CzechiaTesting GIA632 compared to placebo in adults with moderate to severe atopic dermatitis to measure effectiveness and safety
CzechiaStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
CzechiaStudy of Avacopan Safety and Effectiveness in Patients with ANCA-associated Vasculitis
CzechiaEfficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study
CzechiaSafety and Efficacy of Two Doses of OCUL101 Compared with Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration
CzechiaA Phase 3 Study of GSK5733584 with drug combination in patients with platinum‑resistant ovarian cancer
CzechiaA Phase III Randomized Trial of Trilaciclib Dihydrochloride versus Placebo in Adults with Limited‑Stage Small Cell Lung Cancer
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
